000 | a | ||
---|---|---|---|
999 |
_c19253 _d19253 |
||
003 | OSt | ||
005 | 20230428113705.0 | ||
008 | 230428b xxu||||| |||| 00| 0 eng d | ||
040 |
_aAIKTC-KRRC _cAIKTC-KRRC |
||
100 |
_915679 _aDeohate, Pradip P. |
||
245 | _aSynthesis of pyrimidine linked heterocyclic scaffolds by intramolecular cyclization and study of biological potential | ||
250 | _aVol.61(5), May | ||
260 |
_aNew Delhi _bCSIR _c2022 |
||
300 | _a551-557p. | ||
520 | _aSynthesis of some interesting pyrimidine linked heterocyclic scaffolds by intramolecular cyclization has been worked out. Initially compound (4,6-dimethyl-pyrimidin-2-yl-amino)-acetic acid hydrazide has been prepared by reacting 2-amino-4,6-dimethyl pyrimidine with ethyl chloroacetate, followed by condensation with hydrazine hydrate. It has then been treated with N-aryl/alkyl isothiocyanates, followed by intramolecular cyclization using alkaline ethanolic solution of I2 with KI, o-phosphoric acid and aqueous KOH to afford respective heterocyclic compounds with differently substituted pharmacophores viz. (5-aryl/alkyl-amino-[1,3,4]-oxadiazol-2-yl-methyl)-(4,6-dimethyl-pyrimidin-2-yl)-amines, (5-aryl/alkyl-amino-[1,3,4]-thiadiazol-2-yl-methyl)-(4,6-dimethyl-pyrimidin-2-yl)-amines and (4-aryl/alkyl-5-mercapto-[1,2,4]-triazol-3-yl-methyl)-(4,6-dimethyl-pyrimidin-2-yl)-amines. Developments during the synthesis have been monitored by TLC. Constitution of synthesized compounds have been delineated in accordance with equivalent weight, elemental assay,chemical transformation and IR, 1H NMR and mass spectral investigations. Title compounds have been tested for their biological potential. | ||
650 | 0 |
_95009 _aGENERAL CHEMISTRY |
|
700 |
_915677 _aPalaspagar, Kalpana A. |
||
773 | 0 |
_tIndian journal of chemistry (Section B) _x0019-5103 _dNew Delhi NISCAIR-CSIR 2005 |
|
856 |
_uhttp://op.niscpr.res.in/index.php/IJC/article/view/63648 _yClick here |
||
942 |
_2ddc _cAR |